Section Arrow
Quote
MGTX.NASDAQ
- MeiraGTx Holdings plc
Quotes are at least 15-min delayed:2026/04/16 13:18 EDT
Regular Hours
Last
 9.0843
-2.1657 (-19.25%)
Day High 
10.05 
Prev. Close
11.25 
1-M High
11.8499 
Volume 
3.33M 
Bid
9.06
Ask
9.09
Day Low
8.75 
Open
9.55 
1-M Low
7.0112 
Market Cap 
916.27M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 9.72 
20-SMA 8.69 
50-SMA 7.99 
52-W High 11.8499 
52-W Low 4.55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.42/0.36
Enterprise Value
977.42M
Balance Sheet
Book Value Per Share
-0.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
81.39M
Operating Revenue Per Share
0.08
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IMMPImmutep Limited0.5833+0.0393+7.22%-- 
PBMPsyence Biomedical Ltd.6.66+3.78+131.25%-- 
ALLOAllogene Therapeutics2.325+0.155+7.14%-- 
ATAIAtaiBeckley Inc4.035+0.035+0.88%-- 
ACHVAchieve Life Sciences4.7811+1.2311+34.68%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.